Breast Cancer
Multiple Myeloma
Lung Cancer
Immuno-Oncology News
Gynecologic Oncology
Gastrointestinal Cancer
Colorectal Cancer
Ovarian Cancer
Prostate Cancer
Precision Medicine in Oncology
®
Neoadjuvant HER2+
Bone Metastases
Brain Cancer
Business Management
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Genitourinary Cancers
Head & Neck Cancers
Hematologic Oncology
Immunotherapy in GU Cancers
Immunotherapy in Lung Cancer
Immunotherapy in Melanoma
Mantle Cell Lymphoma
Melanoma & Skin Cancer
Non-Hodgkin Lymphoma
Oncology Nursing News
Patient Resources
Sarcomas/TGCT
Special Reports in Personalized Cancer Care
Supportive Care
Online CME
Interactive Publications
SELECT A TOPIC
CURRENT VIEW
All Specialties
▲
Education ▲
Education ▼
Register
|
Login
Conference Coverage
Videos
NewsNetwork
OncLive
®
TV
Peer Exchange
Insights
Attend An Event
State of the Science Summit
Regional Seminar Series
PER Conferences
Giants of Cancer Care
ISGIO
Webinars
OncLive Community
SPECIALTY TOPICS
CURRENTLY VIEWING
All Specialties
Breast Cancer
Multiple Myeloma
Lung Cancer
Immuno-Oncology News
Gynecologic Oncology
Gastrointestinal Cancer
Colorectal Cancer
Ovarian Cancer
Prostate Cancer
Precision Medicine in Oncology
®
Neoadjuvant HER2+
More >>
OncLive TV: Michael Birrer, MD, PhD
<< Back to Our Featured Experts
Dr. Birrer on PARP Inhibitors in Ovarian Cancer
Dr. Birrer on Checkpoint Inhibitors for Endometrial Cancer
Dr. Birrer on Prevalence of Cervical Cancer in the United States
Dr. Birrer on Challenges With Patient Demographics in Cervical Cancer
Dr. Birrer on Patient Preferences for Cervical Cancer Treatment
Dr. Birrer on FDA Approval of Rucaparib in Ovarian Cancer
Dr. Birrer on the Need for Novel Treatment Options in Cervical Cancer
Dr. Birrer on Remaining Challenges in Cervical Cancer
Dr. Michael Birrer on Immunotherapy Potential in Cervical Cancer
Oncology Specialists
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Susan M. O'Brien, MD
Susan M. O'Brien
Juan Manuel O'Connor, MD
Kathleen L. O'Connor, MD
Owen O'Connor, MD, PhD
Owen O'Connor
Peter O'Donnell, MD
Jill O'Donnell-Tormey, PhD
Mark H. O'Hara, MD
David O'Malley, MD
Bert O'Neil, MD
Bert H. O'Neil, MD
Brock O'Neil, MD
Bert O'Neil
Ruth O'Regan, MD
Ruth M. O'Regan, MD
Eileen O'Reilly, MD
Eileen M. O'Reilly, MD
Eileen O'Reilly
Joyce O'Shaughnessy, MD
Joyce A. O'Shaughnessy
Ciara O'Sullivan, MB, BCh
Ana Oaknin, MD
Elias Obeid, MD, MPH
Paul E. Oberstein, MD
Susan M. OBrien, MD
Allyson Ocean, MD
Owen A. OConnor, MD, PhD
Anobel Odisho, MD
Peter ODonnell, MD
Steffi Oesterreich, PhD
Michael D. Offin, MD
William Oh, MD
William K. Oh, MD
Stephen Oh, MD, PhD
Ted Okon
Colleen OLeary, MSN
Gustavo Olivera, PhD
Carl Olsson, MD
Anthony J. Olszanski, MD, RPh
Ruth M. ORegan, MD
Moshe Ornstein, MD
Robert D. Orzechowski, MBA
Raymond U. Osarogiagbon, MD, FACP
C. Kent Osborne, MD
Joyce A. OShaughnessy, MD
Eric M. Ostertag, MD, PhD
Joe OSullivan, MD
Patrick Ott, MD, PhD
Sai-Hong I. Ou, MD
Sai-Hong I. Ou, MD, PhD
Sai-Hong Ignatius Ou, MD, PhD
Michael J. Overman, MD
Beth Overmoyer, MD
Willem Overwijk, PhD
Geoffrey R. Oxnard, MD
Randall A. Oyer, MD
Bert ONeil, MD
Joyce A. OShaughnessy, MD
Evolving HCC Treatment Paradigm: Combinations and Sequencing
Trending Now
FDA Panel to Review Olaparib Application in Metastatic Pancreatic Cancer
New BTK Agents and Combinations Are on the Horizon for B-cell Malignancies
Addressing Belantamab Mafodotin-Related Corneal Events in Myeloma is Key to Continuing Treatment
Patient Factors Critical to Treatment Selection in Prostate Cancer, RCC
Publications
Covering Every Angle of Oncology Practice. Click a cover below, to view more.
x
Subscribe